FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
MedPage Today22h
FTC Sues Top Pharmacy Benefit Managers Over Insulin Prices
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
Federal regulators sue three pharmacy benefit managers over high insulin prices
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...